Connect with us

Financial News

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

Novo Nordisk is currently locked in a bidding war with Pfizer for U.S. biotech firm Metsera.Read More

OUTLAW CHEMICAL FREE SOAPS AND NATURAL BODY PRODUCTS!

PPR MERCH HERE NOW! CLICK THE AD TO SHOP!!!

More in Financial News